Showing 13,841 - 13,860 results of 102,628 for search '(( 50 ((ns decrease) OR (mean decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 13841

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  2. 13842

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  3. 13843

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  4. 13844

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  5. 13845

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  6. 13846
  7. 13847
  8. 13848
  9. 13849
  10. 13850

    DataSheet_1_Zerumbone Modulates α2A-Adrenergic, TRPV1, and NMDA NR2B Receptors Plasticity in CCI-Induced Neuropathic Pain In Vivo and LPS-Induced SH-SY5Y Neuroblastoma In Vitro Mod... by Jasmine Siew Min Chia (8524626)

    Published 2020
    “…Zerumbone treatment markedly decreased the expression of α<sub>2A</sub>-adrenoceptor, while an up-regulation was observed of NMDA NR2B receptors. …”
  11. 13851
  12. 13852
  13. 13853
  14. 13854
  15. 13855
  16. 13856
  17. 13857
  18. 13858
  19. 13859

    Image_5_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Conclusion<p>T2DM is associated with a reduced risk of esophageal, gastric and colorectal cancer and hepatocellular carcinoma in East Asian populations. …”
  20. 13860